The management of visceral pain in patients with disorders of gut–brain interaction, notably
irritable bowel syndrome, presents a considerable clinical challenge, with few available …

Irritable bowel syndrome (IBS) is a spectrum of disorders characterized by abdominal
discomfort and pain, associated with altered bowel habits. Though gut motility, secretion and …

In this mini‐review, we focus on the potential of the endocannabinoid system as a target for
novel therapies to treat gastrointestinal (GI) inflammation. We discuss the organization of the …

Irritable Bowel Syndrome (IBS) is a functional disorder characterized by abdominal pain,
spasms, and altered bowel movements, either predominantly diarrhea (IBS-D), or …

In traditional medicine, Cannabis sativa has been prescribed for a variety of diseases.
Today, the plant is largely known for its recreational purpose, but it may find a way back to …

Stemming from the centuries‐old and well known effects of Cannabis on intestinal motility
and secretion, research on the role of the endocannabinoid system in gut function and …

For centuries, cannabis and its components have been used to manage a wide variety of
symptoms associated with many illnesses. Gastrointestinal (GI) diseases are no exception in …

The actions of cannabis are mediated by receptors that are part of an endogenous
cannabinoid system. The endocannabinoid system (ECS) consists of the naturally occurring …

Background Cannabinoid agents and cannabis are frequently used for relief of diverse
gastrointestinal symptoms. Purpose The objective of this article is to increase the awareness …

Cannabis has been used medicinally for centuries to treat a variety of disorders, including
those associated with the gastrointestinal tract. The discovery of our bodies' own “cannabis …